A Comparison of the Content and Consistency of Quality and Transferability Checklists for Reviewing Economic Evaluations

Author(s)

Lim KK1, Koleva-Kolarova R2, Fox-Rushby J1
1King's College London, London, UK, 2University of Oxford, Oxford, OXF, UK

OBJECTIVES

This research compares the methodological quality and transferability assessments of six checklists using ten economic evaluations of genetic-guided pharmacotherapy for venous thromboembolism and considers implications for systematic reviews and decision making.

METHODS

From a systematic search, we found ten eligible model-based economic evaluations. We applied six checklists (Philips, CHEC-Extended, NICE, EURONHEED, Caro, Welte) to each study to assess methodological quality, and transferability to the UK. The items on each checklist were categorized by three domains (model structure, data identification & analysis, internal & external consistency) and considered whether response options required reporting and/or subjective assessment. Each checklist was applied independently by two reviewers; final ratings were agreed via consensus and discussion with a third reviewer, with all decisions and reasoning documented. The Spearman Rank test compared ordering of study quality between checklists.

RESULTS

For quality, Philips had the widest coverage (≥1 item in most domain-response option pairs, whereas EURONHEED the narrowest (24/26 items reporting structure and data only). Caro gave the widest score range (8-63% “Yes”), followed by Philips (14-57%), NICE (18-55%), CHEC-Extended (55-85%) and EURONHEED (30-57%). However, all checklists identified similar studies with the highest or the lowest scores. Rank correlations were highest between Philips and CHEC-Extended (0.90,p<0.001), and lowest between EURONHEED-NICE (0.45,p>0.05).

For transferability, only EURONHEED had items focusing on reporting only (10/16 items). NICE and Caro identified the same one study as transferable to the UK, which also scored the highest on EURONHEED, whereas Welte did not consider any study transferable.

CONCLUSIONS

Content (domains, response options) of a checklist may affect the conclusions on methodological quality and transferability, which could affect decision on the range of interventions for reimbursement or clinical implementation. Choice of checklists should be justified given decision context and resources available, including a consideration on the use of two checklists for sensitivity analysis.

Conference/Value in Health Info

2021-05, ISPOR 2021, Montreal, Canada

Value in Health, Volume 24, Issue 5, S1 (May 2021)

Code

PPM3

Topic

Economic Evaluation, Health Policy & Regulatory, Health Technology Assessment

Topic Subcategory

Decision & Deliberative Processes, Reimbursement & Access Policy, Trial-Based Economic Evaluation

Disease

Cardiovascular Disorders, Personalized and Precision Medicine

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×